PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-10.69%
Negative net income growth while MRVL stands at 15.63%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
-34.71%
Negative yoy D&A while MRVL is 0.60%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
61.29%
Deferred tax of 61.29% while MRVL is zero at 0.00%. Bruce Berkowitz would see a partial difference that can matter for future cash flow if large in magnitude.
No Data
No Data available this quarter, please select a different quarter.
-378.08%
Both reduce yoy usage, with MRVL at -25.20%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
No Data
No Data available this quarter, please select a different quarter.
50.43%
Inventory shrinking or stable vs. MRVL's 174.91%, indicating lean supply management. David Dodd would confirm no demand shortfall.
No Data
No Data available this quarter, please select a different quarter.
-200.00%
Both reduce yoy usage, with MRVL at -2114.33%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
23.08%
Some yoy increase while MRVL is negative at -100.00%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
-38.66%
Negative yoy CFO while MRVL is 1.58%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
-17.92%
Negative yoy CapEx while MRVL is 16.42%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
-17600.00%
Negative yoy acquisition while MRVL stands at 100.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
57.02%
Purchases well above MRVL's 71.49%. Michael Burry would see major cash outflow into securities vs. competitor’s approach, risking near-term FCF.
23.51%
We have some liquidation growth while MRVL is negative at -44.17%. John Neff notes a short-term liquidity advantage if competitor is holding or restricted.
No Data
No Data available this quarter, please select a different quarter.
152.54%
Investing outflow well above MRVL's 75.32%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
No Data
No Data available this quarter, please select a different quarter.
-2.07%
Both yoy lines negative, with MRVL at -51.90%. Martin Whitman suspects an environment or preference for internal financing over new equity in the niche.
-65.52%
We cut yoy buybacks while MRVL is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.